The Latin America, Middle East and Africa Plasma Fractionation Market would witness market growth of 10.3% CAGR during the forecast period (2021-2027). The plasma fractionation process is majorly dependent on various aspects like solubility of the products, and their physical & chemical conditions like ionic strengths, pH levels, and temperature, etc. the extracted plasma items, also called as Fresh Frozen Plasma (FFP) which are then subjected to several physical and mechanical treatments for virus inactivation like Chromatography centrifugation, detergent/solvent treatment, Nanofiltration, heat treatment, sterile filtration and ultrafiltration with an aim to attain homogeneity of plasma extracted from various donors and cut down the risks of viral transmissions.
The catalyst for the growth of the plasma fractionation market is the increasing geriatric population around the world, which is prone to several rare disorders that requires usage of plasma derivatives. In addition, the growth of the plasma fractionation market would be driven by the increasing utilization of immunoglobulins and alpha-1-antitrypsin in different medicine domain across the world. Moreover, the market growth is also supplemented by the increasing number of plasma collection centers across the world. Furthermore, supportive government initiatives to increase awareness regarding the usage of plasma-derived products are expected to propel the development of the overall plasma fractionation market.
The Private Sector market dominated the South Africa Plasma Fractionation Market by Sector in 2020, thereby, achieving a market value of $405.9 Million by 2027, growing at a CAGR of 10.6 % during the forecast period. The Public Sector market is expected to witness a CAGR of 11.8% during (2021 - 2027).
Based on Product, the market is segmented into Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX. Based on Sector, the market is segmented into Private Sector and Public Sector. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Plasma Fractionation Market is Predict to reach $28.2 Billion by 2027, at a CAGR of 9.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Emergent BioSolutions, Inc., CSL Limited, Grifols S.A., Octapharma AG, Takeda Pharmaceutical Company Limited, Kedrion S.p.A, LFB S.A, Biotest AG (Tiancheng International Investment Limited), Sanquin Blood Supply Foundation, and Bio Products Laboratory Limited.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
By Sector
- Private Sector
- Public Sector
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Emergent BioSolutions, Inc.
- CSL Limited
- Grifols S.A.
- Octapharma AG
- Takeda Pharmaceutical Company Limited
- Kedrion S.p.A
- LFB S.A
- Biotest AG (Tiancheng International Investment Limited)
- Sanquin Blood Supply Foundation
- Bio Products Laboratory Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Plasma Fractionation Market, by Product
1.4.2 LAMEA Plasma Fractionation Market, by Sector
1.4.3 LAMEA Plasma Fractionation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Plasma Fractionation Market by Product
3.1 LAMEA Immunoglobulins Market by Country
3.2 LAMEA Albumin Market by Country
3.3 LAMEA Coagulation factor VIII Market by Country
3.4 LAMEA Coagulation factor IX Market by Country
Chapter 4. LAMEA Plasma Fractionation Market by Sector
4.1 LAMEA Private Sector Market by Country
4.2 LAMEA Public Sector Market by Country
Chapter 5. LAMEA Plasma Fractionation Market by Country
5.1 Brazil Plasma Fractionation Market
5.1.1 Brazil Plasma Fractionation Market by Product
5.1.2 Brazil Plasma Fractionation Market by Sector
5.2 Argentina Plasma Fractionation Market
5.2.1 Argentina Plasma Fractionation Market by Product
5.2.2 Argentina Plasma Fractionation Market by Sector
5.3 UAE Plasma Fractionation Market
5.3.1 UAE Plasma Fractionation Market by Product
5.3.2 UAE Plasma Fractionation Market by Sector
5.4 Saudi Arabia Plasma Fractionation Market
5.4.1 Saudi Arabia Plasma Fractionation Market by Product
5.4.2 Saudi Arabia Plasma Fractionation Market by Sector
5.5 South Africa Plasma Fractionation Market
5.5.1 South Africa Plasma Fractionation Market by Product
5.5.2 South Africa Plasma Fractionation Market by Sector
5.6 Nigeria Plasma Fractionation Market
5.6.1 Nigeria Plasma Fractionation Market by Product
5.6.2 Nigeria Plasma Fractionation Market by Sector
5.7 Rest of LAMEA Plasma Fractionation Market
5.7.1 Rest of LAMEA Plasma Fractionation Market by Product
5.7.2 Rest of LAMEA Plasma Fractionation Market by Sector
Chapter 6. Company Profiles
6.1 Emergent BioSolutions, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Grifols S.A.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.1 Recent strategies and developments:
6.3.1.1 Acquisition and Mergers:
6.4 Octapharma AG
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Approvals:
6.4.2.2 Partnerships, Collaborations, and Agreements:
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Kedrion S.p.A
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 LFB S.A.
6.7.1 Company Overview
6.8 Biotest AG (Tiancheng International Investment Limited)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Sanquin Blood Supply Foundation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Bio Products Laboratory Limited
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Product Launches and Product Expansions:
TABLE 1 LAMEA Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 3 LAMEA Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 4 LAMEA Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 5 LAMEA Immunoglobulins Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Immunoglobulins Market by Country, 2021 - 2027, USD Million
TABLE 7 LAMEA Albumin Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Albumin Market by Country, 2021 - 2027, USD Million
TABLE 9 LAMEA Coagulation factor VIII Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Coagulation factor VIII Market by Country, 2021 - 2027, USD Million
TABLE 11 LAMEA Coagulation factor IX Market by Country, 2017 - 2020, USD Million
TABLE 12 LAMEA Coagulation factor IX Market by Country, 2021 - 2027, USD Million
TABLE 13 LAMEA Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 14 LAMEA Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 15 LAMEA Private Sector Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Private Sector Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Public Sector Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Public Sector Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Plasma Fractionation Market by Country, 2017 - 2020, USD Million
TABLE 20 LAMEA Plasma Fractionation Market by Country, 2021 - 2027, USD Million
TABLE 21 Brazil Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 22 Brazil Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 23 Brazil Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 24 Brazil Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 25 Brazil Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 26 Brazil Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 27 Argentina Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 28 Argentina Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 29 Argentina Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 30 Argentina Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 31 Argentina Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 32 Argentina Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 33 UAE Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 34 UAE Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 35 UAE Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 36 UAE Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 37 UAE Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 38 UAE Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 39 Saudi Arabia Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 40 Saudi Arabia Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 41 Saudi Arabia Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 42 Saudi Arabia Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 43 Saudi Arabia Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 44 Saudi Arabia Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 45 South Africa Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 46 South Africa Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 47 South Africa Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 48 South Africa Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 49 South Africa Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 50 South Africa Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 51 Nigeria Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 52 Nigeria Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 53 Nigeria Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 54 Nigeria Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 55 Nigeria Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 56 Nigeria Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 57 Rest of LAMEA Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 58 Rest of LAMEA Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 59 Rest of LAMEA Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 60 Rest of LAMEA Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 61 Rest of LAMEA Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 62 Rest of LAMEA Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 63 Key Information – Emergent BioSolutions, Inc.
TABLE 64 key Information – CSL Limited
TABLE 65 key information – Grifols S.A.
TABLE 66 Key Information – Octapharma AG
TABLE 67 Key Information – Takeda Pharmaceutical Company Limited
TABLE 68 key Information – Kedrion S.p.A
TABLE 69 Key Information – LFB S.A
TABLE 70 key information – Biotest AG
TABLE 71 Key Information – Sanquin Blood Supply Foundation
TABLE 72 Key Information – Bio Products Laboratory Limited
List of Figures
FIG 1 Methodology for the research